{"id":56444,"date":"2023-05-02T16:06:23","date_gmt":"2023-05-02T14:06:23","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/synaps-dx-president-ceo-frank-amato-named-life-sciences-ceo-of-the-year-in-maryland-tech-council-2023-icon-awards\/"},"modified":"2023-05-02T16:06:23","modified_gmt":"2023-05-02T14:06:23","slug":"synaps-dx-president-ceo-frank-amato-named-life-sciences-ceo-of-the-year-in-maryland-tech-council-2023-icon-awards","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/synaps-dx-president-ceo-frank-amato-named-life-sciences-ceo-of-the-year-in-maryland-tech-council-2023-icon-awards\/","title":{"rendered":"SYNAPS Dx President & CEO, Frank Amato, Named Life Sciences CEO of the Year in Maryland Tech Council 2023 ICON Awards"},"content":{"rendered":"
\n

ROCKVILLE, Md.–(BUSINESS WIRE)–SYNAPS Dx<\/a> (SDx), a privately held company focused on the research, development and commercialization of a diagnostic test for Alzheimer\u2019s disease (AD), is thrilled to announce the Maryland Tech Council<\/a> (MTC), one of the largest technology and life science trade associations in the U.S., has selected Frank Amato, CEO and president, Maryland-headquartered SDx, as the 2023 Life Sciences CEO of the Year at the ICON Awards.<\/p>\n

<\/a>
<\/a><\/p>\n

\n\u201cI\u2019m deeply gratified with this recognition and honored to be among the top technology and life sciences executives in Maryland,\u201d says Amato. \u201cThis award reflects the hard work and accomplishments of the entire SDx team in advancing our goal to educate patients, families and payers on the importance of early detection of AD, encourage lifestyle strategies to prevent cognitive decline and raise awareness on the value of our DISCERN\u2122 test, the first highly accurate, minimally invasive test supporting a clinician\u2019s diagnosis of AD versus other forms of dementia.\u201d<\/p>\n

\nThe MTC selected Amato based upon his performance as an outstanding leader and communicator, making service an integral component of the Company\u2019s growth and profitability and demonstrated ability to take calculated risks that lead to success.<\/p>\n

\n\u201cDISCERN<\/a> is recognized as an important breakthrough for the AD community because there are currently no other autopsy-validated tests that are highly sensitive and highly specific for identifying AD in people recently diagnosed with dementia or mixed-dementia,\u201d continues Amato. \u201cAD is complex but diagnosing it doesn\u2019t have to be. DISCERN provides a definitive diagnosis of AD even in the community setting which is more readily accessible and time- and cost-effective.\u201d<\/p>\n

\nDr. Daniel Alkon, chief scientific advisor, SDx, <\/b>an early pioneer of the SDx diagnostic technology and a finalist in the C-Suite category of the ICON Awards, says, \u201cFrank\u2019s work as a distinguished leader in the life science community ensures that SDx will remain at the forefront of AD innovation. He has assembled a diverse team of passionate and experienced lab technicians, knowledgeable business advisory council members and experienced scientific and medical advisors. His work brings greater awareness of AD among providers, payers and patients and helps all stakeholders to better recognize the symptoms of AD and understand the importance of an accurate diagnosis.\u201d<\/p>\n

\nAbout SYNAPS Dx<\/b><\/p>\n

\nSYNAPS Dx is a privately held company focused on the research, development and commercialization of a diagnostic test for Alzheimer\u2019s disease (AD). The Company offers DISCERN\u2122, the first highly accurate, minimally invasive test supporting a clinician\u2019s definitive diagnosis of AD versus other forms of dementia, even in people recently diagnosed with dementia. SYNAPS Dx\u2019s laboratory is certified under the Clinical Laboratory Improvement Amendments (CLIA) as qualified to perform high complexity clinical laboratory testing. Physicians and patients seeking more information can visit https:\/\/discerntest.com\/<\/a>. For more information on the Company, visit https:\/\/www.synapsdx.com\/<\/a>. Contact: info@synapsdx.com<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia:<\/b>
Caroline Chambers
\n
CPR Communications
\n
cchambers@cpronline.com<\/a>
201.641.1911 x 21<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

ROCKVILLE, Md.–(BUSINESS WIRE)–SYNAPS Dx (SDx), a privately held company focused on the research, development and commercialization of a diagnostic test for Alzheimer\u2019s disease (AD), is thrilled to announce the Maryland Tech Council (MTC), one of the largest technology and life science trade associations in the U.S., has selected Frank Amato, CEO and president, Maryland-headquartered SDx, … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-56444","6":"format-standard","7":"category-industry"},"yoast_head":"\nSYNAPS Dx President & CEO, Frank Amato, Named Life Sciences CEO of the Year in Maryland Tech Council 2023 ICON Awards - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/synaps-dx-president-ceo-frank-amato-named-life-sciences-ceo-of-the-year-in-maryland-tech-council-2023-icon-awards\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SYNAPS Dx President & CEO, Frank Amato, Named Life Sciences CEO of the Year in Maryland Tech Council 2023 ICON Awards - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"ROCKVILLE, Md.–(BUSINESS WIRE)–SYNAPS Dx (SDx), a privately held company focused on the research, development and commercialization of a diagnostic test for Alzheimer\u2019s disease (AD), is thrilled to announce the Maryland Tech Council (MTC), one of the largest technology and life science trade associations in the U.S., has selected Frank Amato, CEO and president, Maryland-headquartered SDx, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/synaps-dx-president-ceo-frank-amato-named-life-sciences-ceo-of-the-year-in-maryland-tech-council-2023-icon-awards\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-02T14:06:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230502005209\/en\/1779432\/21\/mtc.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/synaps-dx-president-ceo-frank-amato-named-life-sciences-ceo-of-the-year-in-maryland-tech-council-2023-icon-awards\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/synaps-dx-president-ceo-frank-amato-named-life-sciences-ceo-of-the-year-in-maryland-tech-council-2023-icon-awards\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"SYNAPS Dx President & CEO, Frank Amato, Named Life Sciences CEO of the Year in Maryland Tech Council 2023 ICON Awards\",\"datePublished\":\"2023-05-02T14:06:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/synaps-dx-president-ceo-frank-amato-named-life-sciences-ceo-of-the-year-in-maryland-tech-council-2023-icon-awards\\\/\"},\"wordCount\":509,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/synaps-dx-president-ceo-frank-amato-named-life-sciences-ceo-of-the-year-in-maryland-tech-council-2023-icon-awards\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230502005209\\\/en\\\/1779432\\\/21\\\/mtc.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/synaps-dx-president-ceo-frank-amato-named-life-sciences-ceo-of-the-year-in-maryland-tech-council-2023-icon-awards\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/synaps-dx-president-ceo-frank-amato-named-life-sciences-ceo-of-the-year-in-maryland-tech-council-2023-icon-awards\\\/\",\"name\":\"SYNAPS Dx President & CEO, Frank Amato, Named Life Sciences CEO of the Year in Maryland Tech Council 2023 ICON Awards - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/synaps-dx-president-ceo-frank-amato-named-life-sciences-ceo-of-the-year-in-maryland-tech-council-2023-icon-awards\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/synaps-dx-president-ceo-frank-amato-named-life-sciences-ceo-of-the-year-in-maryland-tech-council-2023-icon-awards\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230502005209\\\/en\\\/1779432\\\/21\\\/mtc.jpg\",\"datePublished\":\"2023-05-02T14:06:23+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/synaps-dx-president-ceo-frank-amato-named-life-sciences-ceo-of-the-year-in-maryland-tech-council-2023-icon-awards\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/synaps-dx-president-ceo-frank-amato-named-life-sciences-ceo-of-the-year-in-maryland-tech-council-2023-icon-awards\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/synaps-dx-president-ceo-frank-amato-named-life-sciences-ceo-of-the-year-in-maryland-tech-council-2023-icon-awards\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230502005209\\\/en\\\/1779432\\\/21\\\/mtc.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230502005209\\\/en\\\/1779432\\\/21\\\/mtc.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/synaps-dx-president-ceo-frank-amato-named-life-sciences-ceo-of-the-year-in-maryland-tech-council-2023-icon-awards\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SYNAPS Dx President & CEO, Frank Amato, Named Life Sciences CEO of the Year in Maryland Tech Council 2023 ICON Awards\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SYNAPS Dx President & CEO, Frank Amato, Named Life Sciences CEO of the Year in Maryland Tech Council 2023 ICON Awards - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/synaps-dx-president-ceo-frank-amato-named-life-sciences-ceo-of-the-year-in-maryland-tech-council-2023-icon-awards\/","og_locale":"en_US","og_type":"article","og_title":"SYNAPS Dx President & CEO, Frank Amato, Named Life Sciences CEO of the Year in Maryland Tech Council 2023 ICON Awards - Pharma Trend","og_description":"ROCKVILLE, Md.–(BUSINESS WIRE)–SYNAPS Dx (SDx), a privately held company focused on the research, development and commercialization of a diagnostic test for Alzheimer\u2019s disease (AD), is thrilled to announce the Maryland Tech Council (MTC), one of the largest technology and life science trade associations in the U.S., has selected Frank Amato, CEO and president, Maryland-headquartered SDx, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/synaps-dx-president-ceo-frank-amato-named-life-sciences-ceo-of-the-year-in-maryland-tech-council-2023-icon-awards\/","og_site_name":"Pharma Trend","article_published_time":"2023-05-02T14:06:23+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230502005209\/en\/1779432\/21\/mtc.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/synaps-dx-president-ceo-frank-amato-named-life-sciences-ceo-of-the-year-in-maryland-tech-council-2023-icon-awards\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/synaps-dx-president-ceo-frank-amato-named-life-sciences-ceo-of-the-year-in-maryland-tech-council-2023-icon-awards\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"SYNAPS Dx President & CEO, Frank Amato, Named Life Sciences CEO of the Year in Maryland Tech Council 2023 ICON Awards","datePublished":"2023-05-02T14:06:23+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/synaps-dx-president-ceo-frank-amato-named-life-sciences-ceo-of-the-year-in-maryland-tech-council-2023-icon-awards\/"},"wordCount":509,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/synaps-dx-president-ceo-frank-amato-named-life-sciences-ceo-of-the-year-in-maryland-tech-council-2023-icon-awards\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230502005209\/en\/1779432\/21\/mtc.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/synaps-dx-president-ceo-frank-amato-named-life-sciences-ceo-of-the-year-in-maryland-tech-council-2023-icon-awards\/","url":"https:\/\/pharma-trend.com\/en\/synaps-dx-president-ceo-frank-amato-named-life-sciences-ceo-of-the-year-in-maryland-tech-council-2023-icon-awards\/","name":"SYNAPS Dx President & CEO, Frank Amato, Named Life Sciences CEO of the Year in Maryland Tech Council 2023 ICON Awards - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/synaps-dx-president-ceo-frank-amato-named-life-sciences-ceo-of-the-year-in-maryland-tech-council-2023-icon-awards\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/synaps-dx-president-ceo-frank-amato-named-life-sciences-ceo-of-the-year-in-maryland-tech-council-2023-icon-awards\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230502005209\/en\/1779432\/21\/mtc.jpg","datePublished":"2023-05-02T14:06:23+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/synaps-dx-president-ceo-frank-amato-named-life-sciences-ceo-of-the-year-in-maryland-tech-council-2023-icon-awards\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/synaps-dx-president-ceo-frank-amato-named-life-sciences-ceo-of-the-year-in-maryland-tech-council-2023-icon-awards\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/synaps-dx-president-ceo-frank-amato-named-life-sciences-ceo-of-the-year-in-maryland-tech-council-2023-icon-awards\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230502005209\/en\/1779432\/21\/mtc.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230502005209\/en\/1779432\/21\/mtc.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/synaps-dx-president-ceo-frank-amato-named-life-sciences-ceo-of-the-year-in-maryland-tech-council-2023-icon-awards\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"SYNAPS Dx President & CEO, Frank Amato, Named Life Sciences CEO of the Year in Maryland Tech Council 2023 ICON Awards"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56444","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=56444"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56444\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=56444"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=56444"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=56444"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}